Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice.
Authors: Anisimov VN; Piskunova TS; Popovich IG; Zabezhinski MA; Tyndyk ML; Egormin PA; Yurova MV; Rosenfeld SV; Semenchenko AV; Kovalenko IG; Poroshina TE; Berstein LM Year: 2010 Journal: Aging Abstract: Studies in mammals have led to the suggestion that hyperglycemia and hyperinsulinemia are important factors both in aging and in the development of cancer. It is possible that the life-prolonging effects of calorie restriction are due to decreasing IGF-1 levels. A search of pharmacological modulators of insulin/IGF-1 signaling pathway (which mimetic effects of life span extending mutations or calorie restriction) could be a perspective direction in regulation of longevity. Antidiabetic biguanides are most promising among them. The chronic treatment of inbred 129/Sv mice with metformin (100 mg/kg in drinking water) slightly modified the food consumption but failed to influence the dynamics of body weight, decreased by 13.4% the mean life span of male mice and slightly increased the mean life span of female mice (by 4.4%). The treatment with metformin failed influence spontaneous tumor incidence in male 129/Sv mice, decreased by 3.5 times the incidence of malignant neoplasms in female mice while somewhat stimulated formation of benign vascular tumors in the latter. Reference
Integration:
Created on Dec. 4, 2012, 5:12 p.m. Not linked Integrated: False
Comment on This Data Unit